tiprankstipranks
C4 Therapeutics (CCCC)
NASDAQ:CCCC
US Market

C4 Therapeutics Cash flow

84 Followers

C4 Therapeutics Cash Flow

CCCC's free cash flow for Q2 2022 was $-22.72M. For the 2022 fiscal year, CCCC's free cash flow was decreased by $-20.34M and operating cash flow was $-22.20M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 21Dec 20Dec 19Dec 18
Operating Cash Flow
$ -92.82M$ -86.97M$ -67.25M$ 55.61M$ -16.98M
Investing Cash Flow
$ -130.82M$ -189.34M$ -190.50M$ -1.62M$ 36.92M
Financing Cash Flow
$ 1.79M$ 171.40M$ 348.93M$ 244.00K$ 1.96M
Cash Flow From Discontinued Operation
-----
Other Cash Adjustment Inside Changein Cash
-----
End Cash Position
$ 353.28M$ 79.40M$ 184.30M$ 93.13M$ 38.89M
Income Tax Paid Supplemental Data
-$ 0.00$ 143.00K$ 1.09M-
Interest Paid Supplemental Data
$ 1.43M$ 1.31M$ 820.00K$ 0.00-
Issuance Of Capital Stock
$ -469.00K$ 169.47M$ 340.60M$ 0.00$ 2.02M
Issuance Of Debt
-$ 0.00$ 11.97M$ 0.00-
Repayment Of Debt
-----
Free Cash Flow
$ -93.63M$ -88.24M$ -67.90M$ 54.27M$ -19.67M
Domestic Sales
-----
Foreign Sales
-----
Currency in USD

C4 Therapeutics Cash Flow


What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis